APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vascular Endothelial Growth Factor (VEGF) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025188 pages

Choose your research edition.

Industry ResearchVascular Endothelial Growth Factor (VEGF) Inhibitors Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Vascular Endothelial Growth Factor (VEGF) Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Vascular Endothelial Growth Factor (VEGF) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vascular Endothelial Growth Factor (VEGF) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vascular Endothelial Growth Factor (VEGF) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vascular Endothelial Growth Factor (VEGF) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vascular Endothelial Growth Factor (VEGF) Inhibitors include Sanofi., Novartis AG, Bayer AG, Regeneron Pharmaceuticals Inc. and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vascular Endothelial Growth Factor (VEGF) Inhibitors and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vascular Endothelial Growth Factor (VEGF) Inhibitors revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Vascular Endothelial Growth Factor (VEGF) Inhibitors market size, projected growth trends, production technologies, key applications, and end-use industries.

Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Company

Sanofi.

Novartis AG

Bayer AG

Regeneron Pharmaceuticals Inc.

F. Hoffmann-La Roche Ltd.

Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Type

VEGF-D Inhibitor

VEGF-C Inhibitor

VEGF-B Inhibitor

VEGF-A Inhibitor

Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Application

Oncology

Ophthalmology

Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Endothelial Growth Factor (VEGF) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Endothelial Growth Factor (VEGF) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Vascular Endothelial Growth Factor (VEGF) Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vascular Endothelial Growth Factor (VEGF) Inhibitors industry.

Chapter 3: Detailed analysis of Vascular Endothelial Growth Factor (VEGF) Inhibitors companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vascular Endothelial Growth Factor (VEGF) Inhibitorsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of VEGF-D Inhibitor Table 3. Key Players of VEGF-C Inhibitor Table 4. Key Players of VEGF-B Inhibitor Table 3. Key Players of VEGF-A Inhibitor Table 4. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Oncology Table 6. Key Players of Ophthalmology Table 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2021-2026) Table 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2027-2032) Table 12. Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Trends Table 13. Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Drivers Table 14. Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Opportunities and Challenges Table 15. Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Restraints Table 16. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Company (2021-2026) Table 18. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Company Head Office and Area Served Table 20. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Company, Product Type & Application Table 21. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2021-2026) Table 28. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2027-2032) Table 29. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2021-2026) Table 33. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2027-2032) Table 34. Sanofi. Company Information Table 35. Sanofi. Business Overview Table 36. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 38. Sanofi. Recent Development Table 39. Novartis AG Company Information Table 40. Novartis AG Business Overview Table 41. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 43. Novartis AG Recent Development Table 44. Bayer AG Company Information Table 45. Bayer AG Business Overview Table 46. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 48. Bayer AG Recent Development Table 49. Regeneron Pharmaceuticals Inc. Company Information Table 50. Regeneron Pharmaceuticals Inc. Business Overview Table 51. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 53. Regeneron Pharmaceuticals Inc. Recent Development Table 54. F. Hoffmann-La Roche Ltd. Company Information Table 55. F. Hoffmann-La Roche Ltd. Business Overview Table 56. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 58. F. Hoffmann-La Roche Ltd. Recent Development Table 59. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 60. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 61. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 62. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 63. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 64. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) Table 65. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2027-2032) Table 66. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 67. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 68. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 69. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 70. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) Table 72. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2027-2032) Table 73. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 74. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 75. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 76. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 77. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 78. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 79. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 80. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 81. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) Table 83. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2027-2032) Table 84. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 85. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 86. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 87. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 88. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) Table 90. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2027-2032) Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Image Figure 2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type: 2025 VS 2032 Figure 4. VEGF-D Inhibitor Image Figure 5. VEGF-C Inhibitor Image Figure 6. VEGF-B Inhibitor Image Figure 7. VEGF-A Inhibitor Image Figure 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application: 2025 VS 2032 Figure 10. Oncology Image Figure 11. Ophthalmology Image Figure 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2021-2032) Figure 21. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2021-2032) Figure 23. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 24. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032) Figure 25. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032) Figure 26. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 27. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 28. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 30. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 31. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032) Figure 32. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032) Figure 33. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 34. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 35. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 37. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 38. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 40. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 41. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032) Figure 42. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032) Figure 43. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 44. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032) Figure 45. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032) Figure 46. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 47. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 51. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 52. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 57. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 62. UAE Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 64. Chile Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • VEGF-D Inhibitor
  • VEGF-C Inhibitor
  • VEGF-B Inhibitor
  • VEGF-A Inhibitor
Applications
  • Oncology
  • Ophthalmology
Companies covered
  • Sanofi.
  • Novartis AG
  • Bayer AG
  • Regeneron Pharmaceuticals Inc.
  • F. Hoffmann-La Roche Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 VEGF-D Inhibitor
  5. 1.2.3 VEGF-C Inhibitor
  6. 1.2.4 VEGF-B Inhibitor
  7. 1.2.5 VEGF-A Inhibitor
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Oncology
  11. 1.3.3 Ophthalmology
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Trends by Region
  14. 1.5.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2021-2026)
  16. 1.5.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Dynamics
  1. 2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Trends
  2. 2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Drivers
  3. 2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Company (2021-2026)
  2. 3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Company Head office and Area Served
  4. 3.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Company, Product Type & Application
  5. 3.5 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Vascular Endothelial Growth Factor (VEGF) Inhibitors Tier 1, Tier 2, and Tier 3
4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Type
  1. 4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2032)
  3. 4.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2021-2032)
5 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Application
  1. 5.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2032)
  3. 5.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi.
  2. 6.1.1 Sanofi. Company Information
  3. 6.1.2 Sanofi. Business Overview
  4. 6.1.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  6. 6.1.5 Sanofi. Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Bayer AG
  14. 6.3.1 Bayer AG Company Information
  15. 6.3.2 Bayer AG Business Overview
  16. 6.3.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  18. 6.3.5 Bayer AG Recent Developments
  19. 6.4 Regeneron Pharmaceuticals Inc.
  20. 6.4.1 Regeneron Pharmaceuticals Inc. Company Information
  21. 6.4.2 Regeneron Pharmaceuticals Inc. Business Overview
  22. 6.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  24. 6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments
  25. 6.5 F. Hoffmann-La Roche Ltd.
  26. 6.5.1 F. Hoffmann-La Roche Ltd. Company Information
  27. 6.5.2 F. Hoffmann-La Roche Ltd. Business Overview
  28. 6.5.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
7 North America
  1. 7.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032)
  2. 7.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
  3. 7.2.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026)
  4. 7.2.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032)
  5. 7.2.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032)
  6. 7.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
  7. 7.3.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026)
  8. 7.3.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032)
  9. 7.3.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032)
  10. 7.4 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
  11. 7.4.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  13. 7.4.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2027-2032)
  14. 7.4.4 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032)
  2. 8.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
  3. 8.2.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026)
  4. 8.2.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032)
  5. 8.2.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032)
  6. 8.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
  7. 8.3.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026)
  8. 8.3.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032)
  9. 8.3.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032)
  10. 8.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
  11. 8.4.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  13. 8.4.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2027-2032)
  14. 8.4.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032)
  2. 9.2 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
  3. 9.2.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026)
  4. 9.2.2 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032)
  5. 9.2.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032)
  6. 9.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
  7. 9.3.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026)
  8. 9.3.2 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032)
  9. 9.3.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032)
  2. 10.2 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
  3. 10.2.1 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026)
  4. 10.2.2 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032)
  5. 10.2.3 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032)
  6. 10.3 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
  7. 10.3.1 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026)
  8. 10.3.2 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032)
  9. 10.3.3 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032)
  10. 10.4 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
  11. 10.4.1 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  13. 10.4.3 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2027-2032)
  14. 10.4.4 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst